Venous tromboembolism: Diagnosis and management of deep venous thrombosis

Medical Journal of Australia

Volumn 182, Issue 9, 2005, Pages 476-481

  Ho, Wai Khoon ^a   Hankey, Graeme J ^a   Lee, Cindy H ^a   Eikelboom, John W ^b  

^a ROYAL PERTH HOSPITAL   (Australia)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DALTEPARIN; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN; ANTICOAGULANT AGENT;

ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CLINICAL PROTOCOL; DEEP VEIN THROMBOSIS; DISEASE PREDISPOSITION; ECHOGRAPHY; EMBOLECTOMY; FIBRINOLYTIC THERAPY; HIGH RISK POPULATION; HUMAN; LIMB SALVAGE; LONG TERM CARE; PHLEBOGRAPHY; PREVALENCE; PRIMARY PREVENTION; PROBABILITY; RECURRENCE RISK; RECURRENT DISEASE; RISK FACTOR; TREATMENT INDICATION; VENA CAVA FILTER; ALGORITHM; DRUG CONTRAINDICATION; REVIEW; THROMBOEMBOLISM; VEIN THROMBOSIS;

ALGORITHMS; ANTICOAGULANTS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; RISK FACTORS; THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 18744383674     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2005.tb06791.x     Document Type: Article

References (34)

1. Oger E. Incidence of venous thromboembolism: a community-based study in western France. EPI-GETBP Study Group. Groupe d'Etude de la Thrombose de Bretagne Occidentale. Thromb Haemost 2000; 83: 657-660.
2. Lee CH, Hankey GJ, Ho WK, Eikelboom JW. Venous thromboembolism: diagnosis and management of pulmonary embolism. Med J Aust 2005; 182. In press.
3. Heit JA, O'Fallon WM, Petterson TM, et al. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch Intern Med 2002; 162: 1245-1248.
4. Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism. The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 338S-400S.
5. Kearon C. Natural history of venous thromboembolism. Circulation 2003; 107: 122-130.
6. Nielsen HK, Husted SE, Krusell LR, et al. Anticoagulant therapy in deep venous thrombosis: a randomized controlled study. Thromb Res 1994; 73: 215-226.
7. Partsch H, Oburger K, Mostbeck A, et al. Frequency of pulmonary embolism in ambulant patients with pelvic vein thrombosis: a prospective study. J Vasc Surg 1992; 16: 715-722.
8. Partsch H, Kechavarz B, Mostbeck A, et al. Frequency of pulmonary embolism in patients who have iliofemoral deep vein thrombosis and are treated with once- or twice-daily low-molecular-weight heparin. J Vasc Surg 1996; 24: 774-782.
9. Hull R, Delmore T, Genton E, et al. Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis. N Engl J Med 1979; 301: 855-858.
10. Killewich LA, Bedford GR, Beach KW, Strandness DE. Spontaneous lysis of deep venous thrombi: rate and outcome. J Vasc Surg 1989; 9: 89-97.
11. Van Ramshorst B, van Bemmelen PS, Hoeneveld H, et al. Thrombus regression in deep venous thrombosis: quantification of spontaneous thrombolysis with duplex scanning. Circulation 1992; 86: 414-419.
12. Schulman S, Rhedin AS, Lindmarker P, et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. N Engl J Med 1995; 332: 1661-1665.
13. Wells PS, Hirsh J, Anderson DR, et al. Accuracy of clinical assessment of deepvein thrombosis. Lancet 1995; 345: 1326-1330.
14. Wells PS, Anderson DR, Bormanis J, et al. Value of assessment of pretest probability of deep-vein thrombosis in clinical management. Lancet 1997; 350: 1795-1798.
15. Wells PS, Anderson DR, Rodger M, et al. Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. N Engl J Med 2003; 349: 1227-1235.
16. Fancher T, White R, Kravitz R. Combined use of rapid D-dimer testing and estimation of clinical probability in the diagnosis of deep vein thrombosis: systematic review. BMJ 2004; 329: 821-828.
17. Fraser JD, Anderson DR. Deep venous thrombosis: recent advances and optimal investigation with US. Radiology 1999; 211: 9-24.
18. Stevens SM, Elliott CG, Chan KJ, et al. Withholding anticoagulation after a negative result on duplex ultrasonography for suspected symptomatic deep venous thrombosis. Ann Intern Med 2004; 140: 985-991.
19. Hirsh J, Lee AY. How we diagnose and treat deep vein thrombosis. Blood 2002; 93: 3102-3110.
20. Michiels JJ, Kasbergen H, Oudega R, et al. Exclusion and diagnosis of deep vein thrombosis in outpatients by sequential noninvasive tools. Int Angiol 2002; 21:9-19.
21. National Health and Medical Research Council. A guide to the development, implementation and evaluation of clinical practice guidelines. Canberra: NHMRC, 1999.
22. Bates SM, Ginsberg JS. Clinical practice. Treatment of deep vein thrombosis. N Engl J Med 2004; 351: 268-277.
23. Hirsh J, Raschke R. Heparin and low-molecular-weight heparin. The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 188S-203S.
24. Eikelboom J, Baker R. Routine home treatment of deep vein thrombosis is now a reality. BMJ 2001; 322: 1191-1193.
25. Levine MN, Hirsh J, Gent M, et al. A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin. Arch Intern Med 1994; 154: 49-56.
26. Hull RD, Raskob GE, Rosenbloom D, et al, Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis. N Engl J Med 1990; 322: 1260-1264.
27. Levine MN, Raskob G, Beyth RJ, et al. Hemorrhagic complications of anticoagulant treatment. The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 287S-310S.
28. Kearon C. Long term management of patients after venous thromboembolism. Circulation 2004; 110 (Suppl 1): 110-118.
29. Ansell J, Hirsh J, Poller L, et al. The pharmacology and management of the vitamin K antagonists. The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 204S-233S.
30. Pinede L, Ninet J, Duhaut P, et al. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Circulation 2001; 103: 2453-2460.
31. Lee AY, Levine MN, Baker RI, et al. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med 2003; 349: 146-153.
32. Watson LI, Armon MP. Thrombolysis for acute deep vein thrombosis. Cochrane Database Syst Rev 2004; 4: CD002783.
33. Streiff MB. Vena caval filters: a comprehensive review. Blood 2000; 95: 3669-3677.
34. Brandjes DP, Büller HR, Heijboer H, et al. Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet 1997; 349: 759-762.